A detailed history of Invst, LLC transactions in Amgen Inc stock. As of the latest transaction made, Invst, LLC holds 3,232 shares of AMGN stock, worth $1.02 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,232
Holding current value
$1.02 Million
% of portfolio
0.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 16, 2024

BUY
$262.75 - $319.31 $849,208 - $1.03 Million
3,232 New
3,232 $1.01 Million
Q4 2023

Feb 07, 2024

BUY
$255.7 - $288.46 $178,734 - $201,633
699 New
699 $201,000
Q3 2022

Nov 23, 2022

SELL
$224.46 - $253.15 $1,571 - $1,772
-7 Reduced 0.8%
872 $202,000
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $6,229 - $6,931
-27 Reduced 2.98%
879 $222,000
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $1,754 - $1,940
-8 Reduced 0.88%
906 $217,000
Q4 2021

Feb 25, 2022

SELL
$198.88 - $227.6 $47,731 - $54,624
-240 Reduced 20.8%
914 $202,000
Q3 2021

Nov 10, 2021

SELL
$212.27 - $248.7 $13,373 - $15,668
-63 Reduced 5.18%
1,154 $245,000
Q2 2021

Jul 19, 2021

SELL
$233.58 - $259.14 $11,211 - $12,438
-48 Reduced 3.79%
1,217 $302,000
Q1 2021

Jun 23, 2021

SELL
$221.91 - $258.6 $157,112 - $183,088
-708 Reduced 35.88%
1,265 $303,000
Q4 2020

Jun 23, 2021

BUY
$216.38 - $257.67 $86,335 - $102,810
399 Added 25.35%
1,973 $454,000
Q3 2020

Jun 23, 2021

BUY
$234.65 - $260.95 $37,074 - $41,230
158 Added 11.16%
1,574 $402,000
Q2 2020

Jun 23, 2021

SELL
$197.81 - $242.74 $21,165 - $25,973
-107 Reduced 7.03%
1,416 $361,000
Q1 2020

Jun 23, 2021

BUY
$182.24 - $241.7 $277,551 - $368,109
1,523 New
1,523 $301,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Invst, LLC Portfolio

Follow Invst, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invst, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invst, LLC with notifications on news.